| cell line | Q21014462 |
| cancer cell line | Q23058136 |
| P2158 | Cell Line Ontology ID | CLO_0008085 |
| P3289 | Cellosaurus ID | CVCL_1559 |
| P2888 | exact match | http://purl.obolibrary.org/obo/BTO_0002835 |
| http://purl.obolibrary.org/obo/CLO_0008085 | ||
| http://purl.obolibrary.org/obo/EFO_0002291 |
| P9072 | derived from organism type | Homo sapiens | Q15978631 |
| P1343 | described by source | Mutations of the BRAF gene in human cancer | Q27860760 |
| Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer | Q29547564 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers | Q30434796 | ||
| Reconstructing targetable pathways in lung cancer by integrating diverse omics data | Q30679547 | ||
| Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays | Q33882864 | ||
| A gene-alteration profile of human lung cancer cell lines. | Q33978771 | ||
| Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay | Q34661407 | ||
| Mutations and altered expression of p16INK4 in human cancer. | Q35892778 | ||
| Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines | Q36292961 | ||
| TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression | Q36301828 | ||
| NCI-Navy Medical Oncology Branch cell line data base | Q36819549 | ||
| A landscape of pharmacogenomic interactions in cancer. | Q37140236 | ||
| A comprehensive transcriptional portrait of human cancer cell lines | Q37854720 | ||
| A resource for cell line authentication, annotation and quality control | Q38886793 | ||
| Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. | Q39282659 | ||
| Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma | Q39691637 | ||
| Signatures of mutation and selection in the cancer genome | Q39737975 | ||
| Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion | Q40791017 | ||
| Peripheral airway cell differentiation in human lung cancer cell lines | Q41722361 | ||
| Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines | Q42812629 | ||
| Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer | Q44574851 | ||
| Differential Effector Engagement by Oncogenic KRAS. | Q49997178 | ||
| Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. | Q52313314 | ||
| Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium | Q52826622 | ||
| Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization | Q52826635 | ||
| p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features | Q67841746 | ||
| Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation | Q68097374 | ||
| Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines | Q68891179 | ||
| LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer | Q90430597 | ||
| From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later | Q91713872 | ||
| Next-generation characterization of the Cancer Cell Line Encyclopedia | Q91865441 | ||
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines | Q92510255 | ||
| Quantitative Proteomics of the Cancer Cell Line Encyclopedia. | Q92607988 | ||
| Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens | Q93012784 | ||
| P5166 | established from medical condition | bronchiolo-alveolar adenocarcinoma | Q18556553 |
| Q37854720 | A comprehensive transcriptional portrait of human cancer cell lines |
| Q33978771 | A gene-alteration profile of human lung cancer cell lines. |
| Q30434796 | A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers |
| Q37140236 | A landscape of pharmacogenomic interactions in cancer. |
| Q33882864 | Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays |
| Q42812629 | Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines |
| Q52826622 | Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium |
| Q52826635 | Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization |
| Q36819549 | NCI-Navy Medical Oncology Branch cell line data base |
| Q36292961 | Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines |
| Q41722361 | Peripheral airway cell differentiation in human lung cancer cell lines |
| Q44574851 | Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer |
| Q39282659 | Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. |
| Q30679547 | Reconstructing targetable pathways in lung cancer by integrating diverse omics data |
| Q29547693 | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity |
Search more.